Skip to content

DISCLAIMER: This article is a SPONSORED Press Release and does not constitute Finbold's editorial content. Crypto assets/products involve significant risks. Do not invest unless you are prepared to lose your entire investment. For a full disclaimer, please click here.

MATIC and Injective Investors Rush to Join DTX Exchange for Unbelievable Revenue Share Program

Press Releases

Polygon (MATIC) and Injective (INJ) have been on a price-freefall for over a month, driving their investors to speculate about their future performance. However, DTX Exchange (DTX) offers crypto investors in loss a haven to enjoy ground-breaking profits and a chance to join the community of the next biggest marketplace in the crypto sector, surpassing crypto giants like Polygon (MATIC) and Injective (INJ). 

Polygon (MATIC) Price Struggles to Break Free Above $0.51 

Polygon (MATIC) price has performed sluggishly with a 6.5% value depreciation in the last 30 days. Despite the news about the SEC backtracking on Polygon (MATIC) about being a security, the sword still lingers on the project about the hidden agendas of the security firm to increase its control over decentralized projects and cryptos. 

The layer-2 blockchain Polygon (MATIC) continues to move sideways amid bears below the $0.51 threshold and declining active addresses and on-chain traffic. NFT sales have also slowed, making things worse for Polygon (MATIC) as analysts call this price trend a dead end for the MATIC token.  

 Injective (INJ) Sinks 8% This Week Amid Surging Bears

Injective (INJ) leverages the high-performing AI sector but the past few days have neither favored the market nor the crypto. Amid notable outflows from the AI crypto sector, even the recent launch of modular chain-abstraction infrastructure on Injective (INJ) has also failed to invite bulls to push the price to upper levels. 

The cosmos-based blockchain Injective (INJ) currently holds significant bears at the price level of $23.16. Despite the RSI showing a neutral signal, the moving averages indicate a strong sell signal due to a surge in selling pressures. Injective (INJ) is down by 8% on the weekly chart and analysts forecast a potential downtrend to $21 support if bulls fail to regain momentum. 

DTX Exchange Shocks TradFi Sector With Record $1.2M Presale

DTX Exchange (DTX) has surprised the trading sector with its cutting-edge AI-powered hybrid marketplace. The DTX platform offers traders access to 120k+ digital assets from diverse financial sectors including forex, cryptos, equities, and stocks. With its ground-breaking 1000x leverage, traders can maximize gains with higher market positions. 

The DTX tradFi platform enhances trading schemas for diverse communities of traders, offering advanced automation and accessible trading strategies. After grabbing a massive $2 million in the private seed round, the project has raised another $1.2 million in batch 2 of the presale, emerging as the most promising and advanced ICO project in 2024. 

DTX Exchange (DTX) stands out in a competitive market, emerging as the first layer-1 blockchain project at the ICO stage with VulcanX protocols for gas-free trading. The no-KYC DTX token is available at $0.04, ready to jump to $1 once the presale concludes, promising 100x gains to investors.  

Investors Cash In For DTX’s Revenue Sharing Program 

While Injective (INJ) and Polygon (MATIC) are turning bearish, the DTX Exchange emerged as a game-changer for investors with its hybrid trading model, leveraging the best features of centralization and decentralization to solve existing gas fees and security problems among different exchanges. 

Moreover, the hybrid model of DTX Exchange provides traders greater flexibility and efficiency with distributive liquidity pools and staking rewards. DTX Exchange ensures that liquidity is readily available across the platform for 120k+ assets with no slippage and enhanced trading experience.

In its revenue-sharing model, users who contribute liquidity to the pools are rewarded with a share of the platform’s trading fees. Participants in the revenue-sharing program can earn passive income simply by providing liquidity and aligning their interests with the overall success of the exchange. This makes DTX Exchange as the next safest and high-demand exchange, promising to yield high gains for early stakeholders in the ongoing presale. 

Learn more: 

Visit DTX Presale

Join The DTX Community 

Disclaimer

This post is sponsored. Finbold neither endorses nor takes responsibility for the accuracy, quality, advertising, products, or other materials on this page. Readers are strongly encouraged to perform their own research before making any decisions regarding the company. Finbold will not be held accountable, either directly or indirectly, for any harm or loss that may stem from or be linked to the usage or reliance on any information, goods, or services mentioned on the page. If you encounter any issues, kindly report them to [email protected].

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.